4
Changes in Ownership
Gossamer Bio, Inc. Filed Acc 0001857256-26-000004
Options or other derivatives
- EVP, Regulatory Affairs acquired 1,992,203 shares (grant or award)
- EVP, Regulatory Affairs returned 1,992,203 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Peterson Caryn · EVP, Regulatory Affairs
Table II: Derivative
24 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-19 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −506,250 | 0 | D |
| 2026-03-19 | Returned to the company : show line 2 in the form Stock Option (Right to Buy) | −440,000 | 0 | D |
| 2026-03-19 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −375,000 | 0 | D |
| 2026-03-19 | Returned to the company : show line 4 in the form Stock Option (Right to Buy) | −125,000 | 0 | D |
| 2026-03-19 | Returned to the company : show line 5 in the form Stock Option (Right to Buy) | −157,500 | 0 | D |
| 2026-03-19 | Returned to the company : show line 6 in the form Stock Option (Right to Buy) | −157,500 | 0 | D |
| 2026-03-19 | Returned to the company : show line 7 in the form Stock Option (Right to Buy) | −126,667 | 0 | D |
| 2026-03-19 | Returned to the company : show line 8 in the form Stock Option (Right to Buy) | −21,167 | 0 | D |
Loading xslF345X06/wk-form4_1774038052.xml…